The American Journal of Medicine
Volume 122, Issue 1, Supplement , Pages S51-S59 , January 2009

Hypercholesterolemia Treatment Patterns and Low-Density Lipoprotein Cholesterol Monitoring in Patients with a Diagnosis of Atherosclerosis in Clinical Practice

  • Michael H. Davidson, MD

      Affiliations

    • Pritzker School of Medicine, University of Chicago, Chicago, Illinois, USA
    • Corresponding Author InformationRequests for reprints should be addressed to Michael H. Davidson, MD, Radiant Research, 515 North State Street, Suite 2700, Chicago, Illinois 60610
    • ,
  • Sanjay K. Gandhi, PhD

      Affiliations

    • AstraZeneca Pharmaceuticals LP, Wilmington, Delaware, USA
    • ,
  • Robert L. Ohsfeldt, PhD

      Affiliations

    • Department of Health Policy & Management, Texas A&M Health Science Center, College Station, Texas, USA
    • ,
  • Kathleen M. Fox, PhD

      Affiliations

    • Department of Epidemiology & Preventive Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA

  • Image Result

    Hypercholesterolemia therapy patterns in patients with International Classification of Diseases (ICD) code for atherosclerosis. LDL-C = low-density lipoprotein cholesterol.

    Hypercholesterolemia therapy patterns in patients with International Classification of Diseases (ICD) code for atherosclerosis. LDL-C = low-density lipoprotein cholesterol.

  • Image Result

    Distribution of low-density lipoprotein cholesterol (LDL-C) at the time of diagnosis for patients with an International Classification of Diseases (ICD) code for atherosclerosis and a baseline LDL-C m

    Distribution of low-density lipoprotein cholesterol (LDL-C) at the time of diagnosis for patients with an International Classification of Diseases (ICD) code for atherosclerosis and a baseline LDL-C measurement (n = 4,067).

  • Image Result
    Hypercholesterolemia therapy (fibric acid, bile acid sequestrant, niacin, statin, ezetimibe, or combination therapy) patterns stratified by baseline low-density lipoprotein cholesterol (LDL-C) in pati

    Hypercholesterolemia therapy (fibric acid, bile acid sequestrant, niacin, statin, ezetimibe, or combination therapy) patterns stratified by baseline low-density lipoprotein cholesterol (LDL-C) in patients given a diagnosis of atherosclerosis.

  • Image Result
    Distribution of baseline and postdiagnosis low-density lipoprotein cholesterol (LDL-C) values for patients given a diagnosis of atherosclerosis (International Classification of Diseases [ICD] code) an

    Distribution of baseline and postdiagnosis low-density lipoprotein cholesterol (LDL-C) values for patients given a diagnosis of atherosclerosis (International Classification of Diseases [ICD] code) and prescribed hypercholesterolemia therapy (fibric acid, bile acid sequestrant, niacin, statin, ezetimibe, or combination therapy).

 Statement of author disclosure: Please see the Author Disclosures section at the end of this article.

 To access a slide kit for this article, please click here.

PII: S0002-9343(08)01021-8

doi: 10.1016/j.amjmed.2008.10.017

The American Journal of Medicine
Volume 122, Issue 1, Supplement , Pages S51-S59 , January 2009

Article Tools

* Image Usage & Resolution